Search This Blog

Wednesday, March 23, 2016

Amgen To Present Repatha® (Evolocumab) Data At ACC.16

Late-Breaking Phase 3 Study Evaluates Repatha in Statin-Intolerant Patients With High Cholesterol



Amgen - Investors - RSS Content

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.